• LAST PRICE
    0.0600
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0500/ 100
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0600
  • Day Range
    ---
  • 52 Week Range
    Low 0.0100
    High 0.0600
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSTMM
Stemcell Holdings Inc
1.6M
750.0x
---
United StatesPTPI
Petros Pharmaceuticals Inc
2.6M
-0.1x
---
United StatesGBIM
Globeimmune Inc
10.0
0.0x
---
United StatesATHXQ
Athersys Inc
60.0
0.0x
---
United StatesKANT
Kineta Inc
5.5M
-0.3x
---
United StatesRDHL
Redhill Biopharma Ltd
8.6M
0.0x
---
As of 2024-11-22

Company Information

Stemcell Holdings, Inc. is engaged in the regenerative medicine-related business, which provides technical assistance to the culturing, storing and delivery of stem cells, administrative and consulting services to clinics. The Company provides two options for stem cell regenerative therapy: autologous adipose derived mesenchymal stem cells (ADMSC) and natural killer cells (NK). The Company provides coordination services to facilitate its stem cell culturing business. Its coordination services include the introduction of patients to clinics, arranging patients’ schedules, and translating between patients and clinics. The Company offers Internet marketing services by providing search engine optimization for clinics. It also offers property and equipment rental services. The Company operates through its wholly owned subsidiary, Stemcell Co., Ltd.

Contact Information

Headquarters
Omotesando Helene Clinic 3-18-17-6FMINATO-KU, TKY, Japan 107-0062
Phone
---
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.6M
Revenue (TTM)
$10.0M
Shares Outstanding
427.4M
Stemcell Holdings Inc does not pay a dividend.
Beta
---
EPS
$0.00
Book Value
$0.00
P/E Ratio
750.0x
Price/Sales (TTM)
0.2
Price/Cash Flow (TTM)
0.5x
Operating Margin
48.03%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.